Utilizing our advanced technologies related to IV solutions that we have accumulated as a leading company of IV solutions in Japan, the Otsuka Group began selling IV products outside of Japan in the 1970s. Today, we operate 16 group companies in the IV business, helping to advance healthcare in the countries. Most group companies manufacture IV solutions locally, which leads to contributions to their local communities, such as supply of our products at fair prices and employment creation. Furthermore, our export of IV solutions has deepened our involvement in the healthcare of neighboring countries.
Not many of Japan’s pharmaceutical companies supply locally manufactured pharmaceuticals in other countries, due to the risks involved and differences in technical capabilities. However, we insist on manufacturing IV solutions in the country in which they are sold because we believe in supplying pharmaceuticals at fair prices for each country or region so that all people can receive medical treatment equally, whether rich or poor. The Otsuka Global Quality Standards have been set to maintain high quality in every country that manufactures our products, aiming to further improve quality.
We send young engineers to other countries to oversee production, which also presents a huge opportunity for personal growth for those employees. We aim to provide high-value-added products to other countries based on their market needs for ethical pharmaceuticals (primarily IV solutions) and medical foods, thereby contributing to healthcare advancement in those countries.